Free tool
FAERS Monitor: Brevital Sodium
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 011559 or its brand name (Brevital Sodium, Methohexital Sodium). Reports on generic versions are filed under their own applications.
Reports
126
Serious
35
28% of reports
Hospitalization
13
Death reported
2
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective66
- product quality issue25
- off label use8
- drug effect decreased7
- vomiting7
- nausea6
- drug effect less than expected5
- maternal exposure during pregnancy5
- unwanted awareness during anaesthesia5
- hypotension4
- airway complication of anaesthesia3
- blood pressure decreased3
- bradycardia3
- dyspnoea3
- ventricular extrasystoles3
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2005 | 1 |
| 2006 | 3 |
| 2008 | 4 |
| 2009 | 4 |
| 2010 | 7 |
| 2011 | 1 |
| 2012 | 5 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 11 |
| 2016 | 13 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 23 |
| 2020 | 15 |
| 2021 | 7 |
| 2022 | 9 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 7 |
| 2026 | 4 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,033 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| unwanted awareness during anaesthesiaSignal | 5 | 2586.6 | 1088.2 | 10,307 |
| airway complication of anaesthesiaSignal | 3 | 1928.0 | 626.2 | 3,966 |
| drug effect less than expectedSignal | 5 | 56.3 | 23.9 | 219 |
| ventricular extrasystolesSignal | 3 | 48.2 | 15.8 | 96 |
| product quality issueSignal | 25 | 30.7 | 21.6 | 694 |
| drug effect decreasedSignal | 7 | 21.7 | 10.6 | 119 |
| bradycardiaSignal | 3 | 9.4 | 3.1 | 15 |
| maternal exposure during pregnancySignal | 5 | 9.4 | 4.0 | 30 |
| drug ineffectiveSignal | 66 | 8.4 | 7.1 | 448 |
| blood pressure decreasedSignal | 3 | 7.5 | 2.5 | 11 |
| hypotensionSignal | 4 | 3.3 | 1.3 | 4 |
| vomitingSignal | 7 | 2.5 | 1.2 | 5 |
| off label use | 8 | 1.5 | 0.8 | 1 |
| nausea | 6 | 1.3 | 0.6 | 0 |
| dyspnoea | 3 | 0.9 | 0.3 | 0 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.